Causes and consequences of discontinuation of GLP1RAs or tirzepatide

Study: Most Patients Regain Weight and Lose Health Benefits After Stopping GLP-1 Drugs

A study on tirzepatide (a GLP-1 drug) found that after stopping the medication, 82% of participants regained at least 25% of the weight they

What Happens When You Stop Taking GLP-1 Weight Loss Medications

This article examines the experiences of people who stop taking GLP-1 weight loss medications (like Ozempic and Wegovy), exploring what happ

Study: Stopping GLP-1 Drugs Increases Heart Attack and Stroke Risk

New research published in BMJ Medicine reveals that stopping GLP-1 drugs (originally for diabetes, now popular for weight loss) leads to a r

Tirzepatide

Tirzepatide

Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption

This article discusses the rapid uptake and commercial success of GLP-1 receptor agonists for obesity management, highlighting their clinica

GLP-1 drugs show early promise for treating substance use disorders, but evidence remains preliminary

GLP-1 receptor agonists (like semaglutide and tirzepatide), already transformative for obesity and diabetes, are being investigated as a pot